Medication and lifestyle choices both important to lower cholesterol
29 May 2008

Patients need to be advised that anti-cholesterol treatment should not be viewed as compensation for an unhealthy lifestyle, experts warn.

Consultant radiologist Dr Sandy Gupta said that physical, aerobic activity, a balanced diet and healthy weight loss should be encouraged in parallel with drug provision for patients with high cholesterol levels.

However, Dr Gupta added that people who follow a healthy lifestyle are still at risk of cardiovascular disease, explaining that "a lot of our cholesterol is not related to our diet".

Experts advise that greater use of cholesterol lowering medication statins could help many patients who live well but are still at risk of developing heart disease.

According to the British Heart Foundation (BHF), statins are the best way to reduce cholesterol and the risk of heart attack.

The National Institute for Health and Clinical Excellence recently announced new guidance stating that people aged 40-75 who are 20 per cent more likely to develop cardiovascular disease, should receive statin treatment.

Figures show that South Asian and African communities are at higher risk of coronary artery disease and strokes, respectively.

Dr Gupta said: "The death rate from coronary artery disease is 40-50 per cent higher in the south Asian community than in other populations. So, for that particular group, we have to factor in one and a half times excess risk – so a greater number are likely to benefit from statin."

Login and visit the Cholesterol Knowledge Centre

Print Article    Bookmark

• Cholesterol treatment receives US approval 16/12/08
• Study confirms no interference between cholesterol and lymphoma treatments 09/12/08
• New game could help tackle obesity and diabetes in kids, expert claims 04/12/08
• Some "good cholesterol" not good enough, study suggests 02/12/08
• Study links grapes with reduced cardio risk 29/10/08

• ZOCOR (statin) - 51.11%
  ... cholesterol, LDL-cholesterol, apolipoprotein B and triglycerides in primary hypercholesterolaemia, heterozygous familial hypercholesterolaemia or combined (mixed) hyperlipidaemia when response to diet and other non- pharmacological measures is inadequate. To lower LDL:HDL ratio and total cholesterol ...
  
  
• LIPITOR (statin) - 50.64%
  Adjunct to diet for reduction of elevated total cholesterol, LDL- cholesterol, apolipoprotein B, and triglycerides in patients with primary hypercholesterolaemia, heterozygous and homozygous familial hypercholesterolaemia or combined (mixed) hyperlipidaemia when response to diet and other non ...
  
  
• Simvastatin (statin) - 50.64%
  As an adjunct to diet for reduction of total cholesterol, LDL-cholesterol, apolipoprotein B and triglycerides in primary hypercholesterolaemia, heterozygous familial hypercholesterolaemia or combined (mixed) hyperlipidaemia when response to diet and other non- pharmacological measures is inadequate ...
  
  
• LESCOL XL (statin) - 49.42%
  As an adjunct to diet for the reduction of elevated total cholesterol (total-C), low- density lipoprotein cholesterol (LDL-C), apolipoprotein B (apo B) and triglycerides (TG) levels and for the increase of high-density lipoprotein cholesterol (HDL-C) in patients with primary hypercholesterolaemia ...
  
  
• LIPOSTAT (statin) - 48.68%
  ... procedure in patients with a history of either a myocardial infarction or unstable angina pectoris and a total serum cholesterol level in excess of 4.8mmol/L or a LDL- cholesterol in excess of 3.2mmol/ L. Coronary atherosclerotic disease: adjunct to diet to slow progressve course of coronary ...
  
  
• CHOLESTAGEL Film-Coated Tablets - 47.95%
  ... reduction in LDL-cholesterol (LDL-C) levels in patients with primary hypercholesterolaemia who are not adequately controlled with a statin alone. Cholestagel as monotherapy is indicated as adjunctive therapy to diet for reduction of elevated total and LDL-cholesterol in patients with isolated ...